# Maria Tahri

> Maria Tahri is a Series A investor at Alven (Paris) backing Oncology and Health Care. See 2 investments, check sizes, portfolio. Updated Aug 2026.

- Type: Angel Investor
- Fund: [Alven](https://shizune.co/investors/profile/alven-capital)
- Location: Paris, France
- Total investments: 2
- Last investment: Apr 2026
- Lead investor: 100%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/in/maria-tahri-6b530873

Maria Tahri is a Series A investor at Alven in Paris focused on Oncology and Health Care. Maria Tahri joined Alven as an Associate on September 2021. She was the Product Manager of CareOS before that. Maria attended HEC Paris, Polytechnic university, and HEC Lausanne - The Faculty of Business and Economics of the University of Lausanne.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Oncology | 1 | 50% |
| Health Care | 1 | 50% |
| Biotechnology | 1 | 50% |
| Artificial Intelligence | 1 | 50% |

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series A | 1 | 50% |
| Funding Round | 1 | 50% |

### Country

| Country | Investments | Share |
| --- | --- | --- |
| France | 1 | 50% |
| Germany | 1 | 50% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Generare | Generare is a biotech startup that discovers next-generation medicines and high-value molecules hiding in soil bacteria. | $23.1M | Series A | Apr 02, 2026 |  |
| StratifAI | Building the next generation of biomarkers for precision oncology | $14.7M |  | Sep 30, 2025 |  |

2 of 2 investments shown.

## Co-investors
- [Arve Capital](https://shizune.co/investors/profile/arve-capital) — VC Fund, 1 deal together
- [Daphni](https://shizune.co/investors/profile/daphni) — VC Fund, 1 deal together
- [Debiopharm Group](https://shizune.co/investors/profile/debiopharm) — VC Fund, 1 deal together
- [Galion.exe](https://shizune.co/investors/profile/galion-exe) — VC Fund, 1 deal together
- [Heliad AG](https://shizune.co/investors/profile/heliad-equity-partners) — VC Fund, 1 deal together
- [Picus Capital](https://shizune.co/investors/profile/picus-capital) — VC Fund, 1 deal together

## About Alven

VC Fund · Paris, France

Alven Capital is an early-stage venture capital firm with over $500 million under management. Alven backs primarily ambitious French and French-related entrepreneurs in the digital technology space. Alven’s sectors of interest include notably AI, data management platforms, Saas, security solutions, as well as disruptive consumer models with aparticular focus on marketplaces and web brands.

5 contacts available at Alven.

| Name | Title | Profile |
| --- | --- | --- |
| Guillaume Aubin | Co-Founder and Managing Partner | https://shizune.co/investors/profile/guillaume-aubin |
| Maria Tahri | VC investor, Associate | https://shizune.co/investors/profile/maria-tahri |
| Rodolphe Menegaux | Partner | https://shizune.co/investors/profile/rodolphe-menegaux |
| Charles Letourneur | Managing Partner and Co-Founder | https://shizune.co/investors/profile/charles-letourneur |
| François Meteyer | Partner | https://shizune.co/investors/profile/fran%C3%A7ois-meteyer |

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

## FAQ

### What does Maria Tahri invest in?

Maria Tahri invests primarily in Oncology, Health Care and Biotechnology startups, most often at Series A and Funding Round stage. Most of the 2 investments tracked by Shizune back companies in France. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Maria Tahri last invest?

The most recent investment recorded for Maria Tahri closed in Apr 2026. Shizune tracks 2 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co